Imoxat Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

imoxat

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). veterinærlægemidlet kan anvendes som led i en behandlingsstrategi for loppeallergi dermatitis (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). veterinærlægemidlet kan anvendes som led i en behandlingsstrategi for loppeallergi dermatitis (fad).

Bravecto Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

bravecto

intervet international b.v - fluralaner - ectoparasiticides til systemisk brug, isoxazolines - dogs; cats - hunde:- til behandling af kryds og loppe angreb;produktet kan bruges som en del af en behandlingsstrategi for kontrol af loppe allergi dermatitis (fad). - til behandling af demodicosis forårsaget af demodex canis;- til behandling af sarcoptic skab (sarcoptes scabiei var. canis) angreb. - for reduction of the risk of infection with babesia canis canis via transmission by dermacentor reticulatus. [chewable tablets only]cats:- for the treatment of tick and flea infestations;the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). - til behandling af angreb med øremider (otodectes cynotis).

BCG "medac" pulver og solvens til intravesikal suspension Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

bcg "medac" pulver og solvens til intravesikal suspension

medac, gesellschaft für klinische spezialpräparate mbh - bacillus calmette guerin (bcg) stamme rivm deriveret fra stamme 1173-p2, frysetørret (levende) - pulver og solvens til intravesikal suspension

Otisur 23 mg/ml+5 mg/ml+5500 IE/ml øredråber, suspension Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

otisur 23 mg/ml+5 mg/ml+5500 ie/ml øredråber, suspension

chanelle pharmaceuticals manufacturing limited - miconazolnitrat, polymyxin b sulfat, prednisolonacetat - øredråber, suspension - 23 mg/ml+5 mg/ml+5500 ie/ml

Canaural øredråber Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

canaural øredråber

dechra veterinary products a/s - diethanolaminfusidat, framycetinsulfat, nystatin, prednisolon - øredråber

Canaural øredråber Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

canaural øredråber

orifarm a/s - diethanolaminfusidat, framycetinsulfat, nystatin, prednisolon - øredråber

Piptazira 2 g+0,25 g pulver til infusionsvæske, opløsning Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

piptazira 2 g+0,25 g pulver til infusionsvæske, opløsning

pfizer aps - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 2 g+0,25 g

Piptazira 4 g+0,5 g pulver til infusionsvæske, opløsning Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

piptazira 4 g+0,5 g pulver til infusionsvæske, opløsning

pfizer aps - piperacillinnatrium, tazobactamnatrium - pulver til infusionsvæske, opløsning - 4 g+0,5 g

Osurnia Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

osurnia

dechra regulatory b.v. - betamethasone acetate, terbinafine, florfenicol - kortikosteroider og antiinfectives i kombination - hunde - behandling af akut otitis ekstterna.

Surolan Vet. 5 + 23 + 0,529 mg/ml øredråber, suspension og kutansuspension Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

surolan vet. 5 + 23 + 0,529 mg/ml øredråber, suspension og kutansuspension

elanco gmbh - miconazolnitrat, polymyxin b sulfat, prednisolonacetat - øredråber, suspension og kutansuspension - 5 + 23 + 0,529 mg/ml